Pediatrix Medical Group (Pediatrix Medical Group) Operating Income

: $158 Mil (TTM As of Dec. 2023)

View and export this data going back to 1959. Start your Free Trial

Pediatrix Medical Group's Operating Income for the three months ended in Dec. 2023 was $39 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $158 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Pediatrix Medical Group's Operating Income for the three months ended in Dec. 2023 was $39 Mil. Pediatrix Medical Group's Revenue for the three months ended in Dec. 2023 was $496 Mil. Therefore, Pediatrix Medical Group's Operating Margin % for the quarter that ended in Dec. 2023 was 7.86%.

Warning Sign:

Pediatrix Medical Group Inc operating margin has been in a 5-year decline. The average rate of decline per year is -9.8%.

Pediatrix Medical Group's 5-Year average Growth Rate for Operating Margin % was -9.80% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Pediatrix Medical Group's annualized ROC % for the quarter that ended in Dec. 2023 was 7.53%. Pediatrix Medical Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -350.96%.

Pediatrix Medical Group Operating Income Historical Data

The historical data trend for Pediatrix Medical Group's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pediatrix Medical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Income

232.65

171.93

217.74

200.00

157.85

Pediatrix Medical Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Income																55.61	30.04	48.50	40.27	39.04

Pediatrix Medical Group Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $158 Mil.

Pediatrix Medical Group (NYSE:MD) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Pediatrix Medical Group's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	156.164 * ( 1 - 10.49% )	/	( (1942.558	+	1772.345)	/ 2 )
=	139.7823964	/	1857.4515
=	7.53 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2326.339	-	313.701	-	( 124.72	-	max(0, 350.444	-	420.524	+	124.72	))
=	1942.558

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2219.81	-	352.957	-	( 177.743	-	max(0, 388.946	-	483.454	+	177.743	))
=	1772.345

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Pediatrix Medical Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-515.076	/	( ( (147.589 + max(-17.897, 0))	+	(145.933 + max(-54.811, 0)) )	/	2 )
=	-515.076	/	( ( 147.589	+	145.933 )	/	2 )
=	-515.076	/	146.761
=	-350.96 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(277.352	+	0	+	18.452)	-	(313.701	+	0	+	0)
=	-17.897

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(272.313	+	0	+	25.833)	-	(352.957	+	0	+	5.6843418860808E-14)
=	-54.811

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Pediatrix Medical Group's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %	=	Operating Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	39.041	/	496.443
	=	7.86 %

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Pediatrix Medical Group Operating Income Related Terms

Thank you for viewing the detailed overview of Pediatrix Medical Group's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Pediatrix Medical Group (Pediatrix Medical Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pediatrix Medical Group Inc (NYSE:MD) » Definitions » Operating Income

Comparable Companies

Traded in Other Exchanges

MD:Mexico PDC:Germany

Address

1301 Concord Terrace, Sunrise, FL, USA, 33323

Website

https://www.pediatrix.com

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. The company generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.

Executives

James D Swift	officer: EVP, Chief Operating Officer	1301 CONCORD TERRACE, SUNRISE FL 33323
Moore Mary Ann E	officer: EVP Chief ERM/Legal Ops Off	1301 CONCORD TERRACE, SUNRISE FL 33323
Mark S Ordan	director, officer: Chief Executive Officer	7315 WISCONSIN AVENUE, SUITE #250 WEST, BETHESDA MD 20814
Shirley A Weis	director	11621 RESEARCH CIRCLE, GAINESVILLE FL 32615
Sylvia Jean Young	director	C/O LINCOLN EDUCATIONAL SERVICES CORPORA, 14 SYLVAN WAY, STE. A, PARSIPPANY NJ 07054
Lee Wood	officer: EVP, Natl & Market Operations	1301 CONCORD TERRACE, SUNRISE FL 33323
Curtis Pickert	officer: EVP, Chief Operating Officer	1301 CONCORD TERRACE, SUNRISE FL 33323
Laura A Linynsky	director	1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Md Medel	director, officer: PRES. & CHIEF EXEC. OFFICER	1301 CONCORD TERRACE, SUNRISE FL 33323
John C Pepia	officer: Principal Accounting Officer	1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Mack Hinson	officer: Pres., PDX & OBX Medical Group	C/O MEDNAX, INC., 1301 CONCORD TERRACE, SUNRISE FL 33323
C Marc Richards	officer: EVP, Chief Financial Officer	7315 WISCONSIN AVENUE, SUITE 250-W, BETHESDA MD 20814
Dominic J Andreano	officer: Sr.VP,General Counsel & Secy.	1301 CONCORD TERRACE, SUNRISE FL 33323
Nicholas Nikolopoulos	officer: EVP Chf Strategy & Growth Offi	MEDNAX INC, 1301, SUNRISE FL 33323
Guy P Sansone	director	C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323